Published in J Exp Med on June 04, 2001
CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev (2009) 3.09
Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood (2006) 2.11
Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J Exp Med (2002) 1.74
Memory T cells have gene expression patterns intermediate between naive and effector. Proc Natl Acad Sci U S A (2005) 1.18
LIME: a new membrane Raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling. J Exp Med (2003) 1.13
Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies. PLoS One (2008) 1.09
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2010) 1.05
Studies of T-cell activation in chronic inflammation. Arthritis Res (2002) 1.04
Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling. Proc Natl Acad Sci U S A (2016) 1.03
CTLA-4 trafficking and surface expression. Trends Immunol (2008) 1.00
The transmembrane adapter protein SIT regulates thymic development and peripheral T-cell functions. Mol Cell Biol (2005) 0.92
IGSF4 is a novel TCR ζ-chain-interacting protein that enhances TCR-mediated signaling. J Exp Med (2011) 0.87
Normal T-cell development and immune functions in TRIM-deficient mice. Mol Cell Biol (2006) 0.87
Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol (2006) 0.85
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (2004) 0.85
Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4. Front Immunol (2014) 0.83
Stoichiometry and intracellular fate of TRIM-containing TCR complexes. Cell Commun Signal (2010) 0.80
Expression of genes involved in the T cell signalling pathway in circulating immune cells of cattle 24 months following oral challenge with Bovine Amyloidotic Spongiform Encephalopathy (BASE). BMC Vet Res (2015) 0.76
Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface. Immunology (2012) 0.75
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell (1991) 6.30
The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell (1991) 6.13
Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature (1983) 4.96
Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science (1994) 4.23
The T cell receptor. Science (1987) 4.00
Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell (1988) 3.59
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell (1992) 3.11
Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon. Science (1992) 2.67
Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly. J Cell Biol (1989) 2.65
Building a multichain receptor: synthesis, degradation, and assembly of the T-cell antigen receptor. Proc Natl Acad Sci U S A (1987) 2.58
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity (2000) 2.48
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science (1983) 2.21
Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med (1993) 2.17
Selective degradation of T cell antigen receptor chains retained in a pre-Golgi compartment. J Cell Biol (1988) 2.07
CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J (1994) 1.54
In vitro translation and assembly of a complete T cell receptor-CD3 complex. J Exp Med (1997) 1.45
The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors. J Cell Biol (1990) 1.42
Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology (1991) 1.25
Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol (2000) 1.24
T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med (1998) 1.22
Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells. Immunity (1995) 1.19
SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein SKAP55. FEBS Lett (1998) 1.17
Triggering of the alternative pathway of human T cell activation involves members of the T 200 family of glycoproteins. Eur J Immunol (1989) 1.13
Two distinct pathways exist for down-regulation of the TCR. J Immunol (1998) 1.04
TCRzeta is transported to and retained in the Golgi apparatus independently of other TCR chains: implications for TCR assembly. Eur J Immunol (1999) 0.98
The phosphorylation state of CD3gamma influences T cell responsiveness and controls T cell receptor cycling. J Biol Chem (1998) 0.95
LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem (1994) 0.90
Alterations of CD2 association with T cell receptor signaling molecules in "CD2 unresponsive" human T lymphocytes. Eur J Immunol (1993) 0.86
T cell receptor zeta allows stable expression of receptors containing the CD3gamma leucine-based receptor-sorting motif. J Biol Chem (1998) 0.85
Biochemical analysis of the CD45-p56(lck) complex in Jurkat T cells lacking expression of lymphocyte phosphatase-associated phosphoprotein. Int Immunol (1998) 0.85
Identification and functional characterization of the zeta-chain dimerization motif for TCR surface expression. J Immunol (1999) 0.84
The short extracellular domain of the T cell receptor zeta chain is involved in assembly and signal transduction. Mol Immunol (1998) 0.83
T cell receptor alpha-chain tail is required for protein kinase C-mediated down-regulation, but not for signaling. Eur J Immunol (1997) 0.82
Differential cytosolic tail dependence and intracellular fate of T-cell receptors internalized upon activation with superantigen or phorbol ester. Res Immunol (1997) 0.81
The extracellular domain of the zeta-chain is essential for TCR function. J Immunol (1999) 0.78
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 24.61
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell (1996) 11.70
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37
Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP. Eur J Immunol (1999) 5.02
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol (1999) 4.04
Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med (1968) 3.12
Genome evolution at the genus level: comparison of three complete genomes of hyperthermophilic archaea. Genome Res (2001) 2.64
"Aromatic" substituent constants for structure-activity correlations. J Med Chem (1973) 2.54
Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol (1986) 2.17
Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat. J Exp Med (1965) 2.13
Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09
Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes Dev (1991) 2.00
Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Mol Immunol (1989) 1.94
Confidence intervals for weighted sums of Poisson parameters. Stat Med (1991) 1.89
Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol (1999) 1.84
Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol Cell Biol (1996) 1.84
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation (1999) 1.83
A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology (2005) 1.81
CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (2005) 1.76
Negative side-effects of retention sutures for abdominal wound closure. A prospective randomised study. Eur J Surg (2000) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Use of the automicrobic and enteric-tek systems for identification of Enterobacteriaceae. J Clin Microbiol (1982) 1.58
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol (2000) 1.53
Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics (1994) 1.46
The impact of familial loading on gender differences in age at onset of schizophrenia. Acta Psychiatr Scand (1994) 1.44
Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies. Eur Rev Med Pharmacol Sci (2015) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. Eur Heart J (2000) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J (2002) 1.38
Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients. Catheter Cardiovasc Interv (2001) 1.38
Regulation of pyruvate dehydrogenase complex synthesis in Escherichia coli K 12. Identification of the inducing metabolite. Eur J Biochem (1970) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol (1989) 1.34
Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(alpha1*0101,beta1*0401) transgenic mice. Proc Natl Acad Sci U S A (1997) 1.34
Molecular cloning of SKAP55, a novel protein that associates with the protein tyrosine kinase p59fyn in human T-lymphocytes. J Biol Chem (1997) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells. J Biol Chem (2001) 1.32
Molecular interaction between the Fyn-associated protein SKAP55 and the SLP-76-associated phosphoprotein SLAP-130. J Biol Chem (1998) 1.31
Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J Biol Chem (2001) 1.29
T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci U S A (1998) 1.28
Laparoscopic cholecystectomy: technical performance, safety and patient's benefit. Endoscopy (1992) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.26
Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol (2001) 1.25
Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest (1998) 1.24
Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J Pharm Sci (1987) 1.23
T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med (1998) 1.22
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum (1993) 1.22
Fatal nonbacterial pneumonia associated with Adenovirus type 4. Occurrence in an adult. JAMA (1967) 1.20
T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density. Int Immunol (1999) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Calculation of hydrophobic constant (log P) from pi and f constants. J Med Chem (1975) 1.19
SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. Curr Biol (1999) 1.18
Sudden infant death. Normal cardiac habituation and poor autonomic control. N Engl J Med (1974) 1.18
SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein SKAP55. FEBS Lett (1998) 1.17
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy. Clin Exp Rheumatol (1993) 1.16
Mediators of inflammation in leukocyte lysosomes. VII. Observations on mast cell-rupturing agents in different species. Lab Invest (1968) 1.15
Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry (2000) 1.15
Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM. Mol Cell Biol (2005) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol (1992) 1.13
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation (2000) 1.11
Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology (1996) 1.11
[Introduction of the new DRG-based reimbursement system in German hospitals--a difficult operation? Experiences and possible solutions from the viewpoint of trauma surgery]. Unfallchirurg (2001) 1.11
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol (2012) 1.09
Expression of glutamate carboxypeptidase II in human brain. Neuroscience (2006) 1.09
Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. J Med Chem (1982) 1.08
The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol Lett (1995) 1.08
Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia (2012) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Biomarkers of oxidative stress and DNA damage in agricultural workers: a pilot study. Toxicol Appl Pharmacol (2007) 1.07
Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release. Lancet (1992) 1.06
Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis. Best Pract Res Clin Rheumatol (2011) 1.05
Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin. J Biol Chem (2000) 1.05
Adverse drug reactions. An epidemiological study at psychiatric hospitals. Acta Psychiatr Scand (1984) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion (2000) 1.04
Two distinct pathways exist for down-regulation of the TCR. J Immunol (1998) 1.04
Nestin-expressing cells in the gut give rise to enteric neurons and glial cells. Neurogastroenterol Motil (2012) 1.03
Leucine-based receptor sorting motifs are dependent on the spacing relative to the plasma membrane. J Biol Chem (1998) 1.03
Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav (2013) 1.03
SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation. J Exp Med (1999) 1.03
Distinct domains of the CD3-gamma chain are involved in surface expression and function of the T cell antigen receptor. J Biol Chem (1995) 1.02
Structure-activity relationships in antitumor aniline mustards. J Med Chem (1978) 1.02
Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein. Folia Biol (Praha) (1990) 1.02
Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur J Immunol (1997) 1.00
Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer (2001) 1.00
Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J Immunol (1999) 1.00
Archived polyacrylamide gels as a resource for proteome characterization by mass spectrometry. Electrophoresis (2001) 0.99